Micro-osteoperforations and Tooth Movement

November 24, 2017 updated by: Amal Alkebsi, Jordan University of Science and Technology

Micro-osteoperforations and Tooth Movement: A Randomized Controlled Clinical Trial

The purpose of this study is determine the effect the Microosteoperforation (MOPs) using the miniscrew on the rate tooth movement. Moreover, measurement of the level of the pain and pain's interference, the level of satisfaction and comfort using this protocol. Finally root resorption associate with this technique will be evaluated.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study will be randomized, split mouth design controlled trial with a 1:1 allocation ratio. One resident (A.A), calibrated by the main supervisor (S.M), will be reliable for recruiting the subjects, undertaking the orthodontic treatment under the supervision. The eligibility of the cases will be reevaluated by main supervisor (E.M) before the start of treatment.

Split mouth design will be utilized with MOPs that will be randomly assigned to the patients' left or right sides to eliminate the possibility of uneven occlusal forces because of habitual occlusion predominantly on 1 side and also the eliminate the biological variability between subjects. The allocation sequence will be concealed from the researcher (A.A) enrolling and assessing participants in sequentially numbered, opaque, sealed and stapled envelopes with the participant's the name and date of birth are written before the intervention. Allocation concealment seeks to prevent selection bias, protects the assignment sequence until allocation.

A Ethical approval will be granted by Jordan University of science and technology research center, and permission will be given at postgraduate dental clinics at Jordan University of science and technology, Irbid, Jordan.

We hypothesized that 50% increased in rate of tooth movement in MOP group would produce a clinically significant difference. The sample size was calculated depend on a type I error frequency of 5%. According to the power analysis and assuming a large effect size difference between groups with 50% of acceleration rate of tooth movement, the power analysis yields a total sample size estimate of 44 samples at a conventional alpha-level (p = 0.05) and desired power (1 - β err prob) of 0.90, yielding 22 samples per group (means 22 patients that represent 22 MOP group and 22 Control group). Assuming an overall attrition rate of 15%, initial recruitment should target a total of 55 samples with 18 patients per group. All calculations were performed with the computer application G-Power (Erdfelder et al., 1996)

Study Type

Interventional

Enrollment (Actual)

35

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Irbid, Jordan, 22110
        • Jordan University of Science and Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 26 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male and female
  • between 16 to 26 years old
  • Class II Division 1 malocclusion or bimaxillary protrusion
  • Average Lower facial height and Mandibular plane angle
  • No systemic disease
  • Healthy periodontal condition
  • Non smoker
  • Probing depth less than 4 mm in all teeth

Exclusion Criteria:

  • Long-term use of any Medication
  • Poor oral hygiene
  • Low and high angle cases
  • Systemic disease
  • Evidence of bone loss
  • Active periodontal disease
  • Smoker
  • Probing depth more than 4 mm in all teeth

Cephalometric analysis of the included subjects was performed at baseline including

  1. Sella-Nasion to A Point Angle (SNA): Measure Description: Sella-Nasion-A point (SNA) indicates the horizontal position of the maxilla relative to the cranial base.
  2. Sella-Nasion to B Point Angle (SNB): Sella-Nasion-B point (SNB) indicates the horizontal position of the mandible relative to the cranial base.
  3. A point to B Point Angle (ANB): A point- Nasion-B point (ANB) indicates the skeletal relationship between the maxilla and mandible.
  4. Maxillary mandibular plane angle (MM): The angle formed between the Maxillary Plane and Mandibular Plane. Maxillary Plane is the plane demonstrated by a line through the anterior and posterior nasal spines.A mandibular plane is a plane demonstrated by a line through the gonion and menton.
  5. Lower anterior facial height(LAFH)
  6. Upper incisor inclination: The angle between the maxillary plane and the axis of the maxillary incisors.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MOP side
Three small holes in cortical bone can be created by Miniscrews.Before application of the MOPs, Patient will be asked to wash their mouth twice by chlorhexidine for 1 minute. Local anesthesia will be given (2% lidocaine with 1:100,000 epinephrine). Microosteoperforation (MOPs) will be performed distal to canine.
Three Micro-osteoperforation (MOPs) will be performed distal to canine by Mini screw. Before the application of the MOPs, Patient will be asked to wash their mouth twice by chorhexidine for 1 minute.
Other Names:
  • Selective alveolar decortication
No Intervention: control side
No intervention in the other side of maxilla (control side)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
3D Digital Model Measurements of Canine Rate of Tooth Movement
Time Frame: Baseline to 1st month
The baseline 3D digital model was superimposed to 3D digital models of the 1st month to determine the anterioposterior displacement of canines.
Baseline to 1st month
3D Digital Model Measurements of Canine Rate of Tooth Movement
Time Frame: Baseline to 2nd month
The baseline 3D digital model was superimposed to 3D digital models of 2nd month to determine the anterioposterior displacement of canines.
Baseline to 2nd month
3D Digital Model Measurements of Canine Rate of Tooth Movement
Time Frame: Baseline to 3rd month
The baseline 3D digital model was superimposed to 3D digital models of 3rd month to determine the anterioposterior displacement of canines.
Baseline to 3rd month
Intra Oral Measurements of Canine Rate of Tooth Movement
Time Frame: Baseline to 1st month
Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.
Baseline to 1st month
Intra Oral Measurements of Canine Rate of Tooth Movement
Time Frame: Baseline to 2nd month
Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.
Baseline to 2nd month
Intra Oral Measurements of Canine Rate of Tooth Movement
Time Frame: Baseline to 3 month
Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.
Baseline to 3 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Root Resorption
Time Frame: Baseline to 3rd month
It will be evaluated by taking periapical radiograph for canines before canine retraction and after 3 months period
Baseline to 3rd month
Pain Intensity
Time Frame: within 7 days after the intervention
It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.
within 7 days after the intervention
Pain Interference /Pain During Eating?
Time Frame: within 7 days after the intervention
It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.
within 7 days after the intervention
Pain Interference /Pain Interrupted Sleep
Time Frame: within 7 days after the intervention
It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.
within 7 days after the intervention
Pain Interference /Swelling of the Surgical Side
Time Frame: within 7 days after the intervention
It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no swelling and 10 = worst swelling.
within 7 days after the intervention
Pain Interference /Discomfort
Time Frame: within 7 days after the intervention
It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no discomfort and 10 = worst discomfort.
within 7 days after the intervention
Patient Satisfaction
Time Frame: After 7 days of MOP application
It will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = unsatisfied and 10 = most satisfaction.
After 7 days of MOP application
Menstrual Cycle
Time Frame: within 3 months
the relationship between the rate of tooth movement and Menstrual cycle
within 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amal A Alkebsi, MClinDent, Jordan University of Science and Technology
  • Principal Investigator: Emad Al Maaitah, Ph.D., Jordan University of Science and Technology
  • Principal Investigator: Hisham Alshorman, Ph.D., Jordan University of Science and Technology
  • Principal Investigator: Elham S. Abu Alhaija, Ph.D, Jordan University of Science and Technology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

November 1, 2016

Study Completion (Actual)

November 1, 2016

Study Registration Dates

First Submitted

April 16, 2015

First Submitted That Met QC Criteria

June 12, 2015

First Posted (Estimate)

June 16, 2015

Study Record Updates

Last Update Posted (Actual)

November 28, 2017

Last Update Submitted That Met QC Criteria

November 24, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Upon request.

IPD Sharing Time Frame

As soon as it published and it to be available anytime.

IPD Sharing Access Criteria

Official departments of recognized universities

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malocclusion

Clinical Trials on Micro-osteoperforation

Subscribe